NINDS grant will enable chemist Matthew Disney, PhD, to study neurological disease treatments

Chemistry professor Matthew Disney, PhD, has been awarded a prestigious Research Program Award by the National Institute of Neurological Disorders and Stroke (NINDS) to aid Disney’s development of potential breakthrough treatments for neurological diseases such as Alzheimer’s, Parkinson’s and ALS. The NINDS award lasts for five years and is extendable for up to eight.

Matthew Disney, PhD